Bladder cancer biotech Viventia Bio files for an $86 million IPO

October 22, 2015

The Winnipeg, Canada-based company, which was founded in 1995, plans to list on the Nasdaq under the symbol VITA. Viventia Bio filed confidentially on September 17, 2015

 

Read more here.

Share This Story

Back